You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV-18

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HSIL of Cervix Trial in Heze (NWRD08)

Recruiting
  • HSIL of Cervix
  • NWRD08
  • Heze, Shandong, China
    Heze Municipal Hospital
Jun 6, 2023

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,

Not yet recruiting
  • Cervical Cancer
  • +6 more
  • Fludarabine + Cyclophosphamide
  • HRYZ-T101 TCR-T Cell
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine

Not yet recruiting
  • Cervical Cancer
  • +5 more
  • HRYZ-T101 Injection
  • Fludarabine + Cyclophosphamide
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 17, 2023

Head and Neck Squamous Cell Carcinoma Trial in Seoul (nivolumab-GX-188E-GX-I7)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 20, 2022

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial

Recruiting
  • Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
  • +3 more
  • Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
  • L'Hospitalet De Llobregat, Catalunya, Spain
    Gynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

CZ Using the Detection of HPV DNA and CINtec Plus

Completed
  • Algorithm for Cervix Carcinoma Screening
  • HPV DNA test with selective HPV 16/18 genotyping (cobas® 4800 HPV Test, Roche)
  • +2 more
  • Praha, Czech Republic, Czechia
    Aeskulab Patologie, ks
Oct 11, 2022

Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis

Enrolling by invitation
  • Cervical Carcinoma
  • Human Papillomavirus Infection
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +3 more
  • Liberia, Guanacaste, Costa Rica
    Agencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
  • Guangzhou, Guangdong, China
  • +2 more
Dec 30, 2022

Human Papillomavirus Vaccination Trial in Louise (Counseling)

Enrolling by invitation
  • Human Papillomavirus Vaccination
  • Counseling
  • Louise, Mississippi
    Plan A Health, Inc
Dec 19, 2022

Human Papillomavirus Infections Trial in Belgium, United States (Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18)

Terminated
Has Results
  • Human Papillomavirus Infections
  • Ad26.HPV16
  • +3 more
  • Doral, Florida
  • +11 more
Nov 23, 2021

Anal Tumor Trial in Chicago, New York, Québec (VGX-3100, CELLECTRA™ 5PSP)

Completed
  • Anal Neoplasm
  • VGX-3100
  • CELLECTRA™ 5PSP
  • Chicago, Illinois
  • +2 more
Dec 6, 2021

Women Who Received One, Two, and Three Doses of HPV Vaccine in

Active, not recruiting
  • Human Papillomavirus Infection
  • Biospecimen Collection
  • +2 more
  • Liberia, Guanacaste, Costa Rica
    Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Aug 11, 2022

Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • GARDASIL® 9
  • Kunming, Yunnan, China
    Yunnan Center for Disease Prevention and Control
Dec 23, 2022

HPV Infection, HPV Vaccination Trial in Thika (Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine)

Recruiting
  • HPV Infection
  • HPV Vaccination
  • Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
  • Thika, Kiambu, Kenya
    Phrd-Ccr-Kemri
Jun 22, 2022

Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi

Active, not recruiting
  • Human Papilloma Virus Infection Type 16
  • +4 more
  • HPV+MMR（0d），HPV（6m）
  • +2 more
  • Shaoxing, Zhejiang, China
  • +1 more
Mar 14, 2022

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia, Vulvar Intraepithelial Neoplasia (VIN) Trial in

Completed
  • Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
  • +6 more
  • VGX-3100
  • +2 more
  • Newark, Delaware
  • +14 more
Dec 6, 2021

Condylomata Acuminata Trial (low dosage HPV Vaccine, medium dosage HPV Vaccine, high dosage HPV Vaccine)

Completed
  • Condylomata Acuminata
  • low dosage HPV Vaccine
  • +3 more
  • (no location specified)
May 23, 2022

Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive

Active, not recruiting
  • Human Papillomavirus-Related Carcinoma
  • +5 more
  • HPV Specific T Cells
  • +3 more
  • Houston, Texas
    Houston Methodist Hospital
Jan 10, 2022

HPV InfectioN, HPV-Related Carcinoma Trial in China (Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell), )

Active, not recruiting
  • HPV InfectioN
  • HPV-Related Carcinoma
  • Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）
  • placebo
  • Nanning, Guangxi, China
  • +4 more
Sep 10, 2023

Head and Neck Squamous Cell Carcinoma Trial in Seoul (GX-188E+GX-I7+Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
May 18, 2022

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022